Search

Search Constraints

You searched for: Date 2017 Author/Creator Adam, Julien

Search Results

1. Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids. (April 2017)

2. Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy. (2nd September 2017)

3. High proportion of PD‐1‐expressing CD4+ T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence. Issue 12 (28th August 2017)

4. Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. (1st February 2017)

5. Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non–small cell lung cancer. (November 2017)

6. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. (2nd January 2017)

8. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer. (2nd January 2017)

9. Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients. (October 2017)

10. Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series. Issue 1 (January 2017)